YOLFTbeta
Apyx Medical Inc

Apyx Medical Inc

APYX · NASDAQ · Healthcare / Medical Devices

2.81USD-0.08 (-2.77%)

Price History

Full chart

Market Stats

Previous Close2.89
Open2.85
Day Range2.65 – 2.85
52-Week Range2.01 – 5.08
Volume43.01K
Market Cap124.69M
P/E (TTM)0.00
Forward P/E72.46
EPS-0.20
Dividend Yield0.00%
Beta1.31
50-Day Avg3.39
200-Day Avg3.75

About

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Charles D. Goodwin II
  • Employees205
  • Headquarters5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004, USA
  • Websitehttps://apyxmedical.com

Leadership

  • Mr. Charles D. Goodwin IIPresident, CEO & Director · b. 1966
  • Mr. Matthew C. Hill CPACFO, Treasurer & Secretary · b. 1969
  • Mr. Shawn D. RomanChief Operating Officer · b. 1972
  • Mr. Moshe CitronowiczSenior Vice President · b. 1953
  • Ms. Dolores CataniaChief of Confidence

Financials

Income Statement

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.52M7.49M7.37M8.44M9.60M9.94M11.48M12.45M16.55M20.50M20.21M26.68M28.78M28.10M26.95M24.23M25.41M27.67M23.66M27.68M29.52M36.63M38.88M16.69M28.23M27.71M48.52M44.51M52.35M48.10M52.84M
Growth (%)-+35.59%-1.53%+14.52%+13.69%+3.53%+15.58%+8.38%+32.97%+23.83%-1.39%+31.99%+7.88%-2.37%-4.07%-10.10%+4.87%+8.89%-14.50%+16.99%+6.64%+24.08%+6.16%-57.09%+69.21%-1.86%+75.08%-8.26%+17.61%-8.11%+9.86%
Cost of Revenue3.22M4.13M4.14M5.27M4.59M4.60M5.72M7.19M9.43M12.51M12.65M16.08M17.46M16.25M15.10M14.24M14.68M16.34M14.46M18.69M16.96M18.71M19.12M5.89M9.14M10.21M14.92M15.38M18.59M18.74M33.81M
Gross Profit2.31M3.35M3.23M3.17M5.01M5.34M5.76M5.26M7.12M7.98M7.56M10.60M11.32M11.85M11.85M9.99M10.73M11.33M9.20M8.99M12.56M17.91M19.76M10.79M19.09M17.50M33.60M29.13M33.76M29.36M19.03M
Gross Margin41.76%44.77%43.85%37.53%52.19%53.74%50.15%42.23%43.00%38.94%37.41%39.74%39.32%42.17%43.98%41.22%42.23%40.96%38.88%32.48%42.54%48.91%50.82%64.68%67.63%63.17%69.26%65.45%64.49%61.04%36.02%
Operating Expense2.53M2.87M2.89M4.09M7.16M4.81M5.18M5.73M6.40M6.70M7.16M7.98M9.21M10.56M11.14M12.74M10.75M10.29M12.86M14.84M19.54M21.71M25.03M24.39M39.96M37.59M48.05M52.69M51.02M48.20M25.48M
Operating Income-219.50K480.40K339.58K-920.16K-2.15M529.90K583.58K-473.89K712.40K1.28M403.97K2.62M2.11M1.29M714.85K-2.75M-18.00K1.05M-3.67M-5.85M-6.99M-3.79M-5.26M-13.60M-20.87M-20.08M-14.45M-23.56M-17.26M-18.84M-6.45M
Operating Margin-3.98%6.42%4.61%-10.90%-22.38%5.33%5.08%-3.81%4.30%6.24%2.00%9.84%7.32%4.60%2.65%-11.36%-0.07%3.78%-15.49%-21.13%-23.67%-10.35%-13.54%-81.51%-73.91%-72.47%-29.78%-52.94%-32.97%-39.18%-12.20%
EBITDA-105.80K741.00K616.43K-133.07K947.21K926.71K1.16M-199.02K1.11M1.67M949.84K3.15M2.88M3.81M1.79M-1.23M1.19M1.93M-3.68M-4.97M-6.17M-3.06M-13.01M-13.92M-19.07M-18.48M-13.91M-22.01M-18.11M-16.80M-4.59M
EBITDA Margin-1.92%9.90%8.36%-1.58%9.87%9.33%10.07%-1.60%6.70%8.17%4.70%11.82%10.00%13.56%6.64%-5.08%4.70%6.97%-15.56%-17.97%-20.91%-8.35%-33.45%-83.41%-67.55%-66.67%-28.66%-49.44%-34.60%-34.93%-8.69%
Net Income-154.10K407.30K99.19K-998.05K-2.18M500.63K784.29K-514.76K681.32K1.51M406.21K2.68M2.40M1.83M595.52K-1.53M109.00K617.00K-4.34M-17.28M-5.37M-3.95M-5.06M64.01M-19.71M-11.90M-15.17M-23.18M-18.71M-23.46M-11.21M
Net Income Margin-2.79%5.44%1.35%-11.82%-22.75%5.04%6.83%-4.14%4.12%7.38%2.01%10.06%8.34%6.52%2.21%-6.34%0.43%2.23%-18.34%-62.43%-18.19%-10.78%-13.02%383.61%-69.79%-42.93%-31.27%-52.09%-35.75%-48.78%-21.22%
R&D121.90K105.70K96.74K183.17K379.83K513.02K463.13K693.71K717.35K907.39K985.81K1.19M1.64M2.06M2.08M1.85M1.20M1.33M1.26M1.42M2.16M2.62M2.46M2.47M3.73M3.92M4.32M4.54M4.84M5.08M3.37M
R&D as % of Total Revenue2.21%1.41%1.31%2.17%3.96%5.16%4.03%5.57%4.33%4.43%4.88%4.45%5.71%7.33%7.73%7.65%4.71%4.80%5.33%5.12%7.32%7.15%6.31%14.80%13.21%14.15%8.91%10.21%9.25%10.56%6.38%
Interest Expense68.70K75.80K0103.84K066.80K70.69K48.45K34.06K15.09K22.70K16.16K2.47K58.46K76.37K223.00K249.00K232.00K237.00K151.00K158.00K158.00K136.00K104.00K8.00K46.00K10.00K15.00K2.48M5.91M5.59M
Interest Expense % of Total Revenue1.24%1.01%0.00%1.23%0.00%0.67%0.62%0.39%0.21%0.07%0.11%0.06%0.01%0.21%0.28%0.92%0.98%0.84%1.00%0.55%0.54%0.43%0.35%0.62%0.03%0.17%0.02%0.03%4.73%12.28%10.58%

Balance Sheet

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.60M3.90M3.84M10.66M7.34M7.91M8.58M8.50M9.23M11.02M11.77M16.69M18.82M25.78M27.58M27.79M28.24M28.18M33.18M24.83M31.45M35.11M30.99M95.61M84.68M74.11M68.72M51.77M79.24M64.84M66.84M
Total Liabilities3.19M1.88M1.61M1.37M1.33M1.52M1.58M2.01M1.78M1.76M1.83M2.51M2.03M6.99M6.43M6.02M6.12M5.29M11.85M20.14M8.04M8.89M8.96M7.84M13.42M10.25M14.71M13.98M52.32M50.51M52.01M
Total Equity412.30K2.02M2.22M9.29M6.01M6.39M7.00M6.49M7.45M9.26M9.80M14.06M16.79M18.79M21.15M21.77M22.12M22.89M21.33M4.69M23.40M26.22M22.03M87.77M71.26M63.72M53.70M37.58M26.70M14.21M14.54M
Cash165.80K120.90K48.25K278.67K415.07K278.66K578.35K379.21K306.14K2.29M1.30M2.95M3.53M2.56M2.15M3.83M4.88M4.16M7.92M5.73M11.80M14.46M9.95M16.47M58.81M41.91M30.87M10.19M43.65M31.74M31.74M
Total Debt811.20K685.30K878.87K580.41K663.57K572.93K672.31K968.80K415.34K379.99K348.33K161.95K-4.00M5.09M4.02M4.22M3.50M9.01M16.02M3.58M3.07M2.83M140.00K1.13M676.00K305.00K796.00K38.50M38.76M39.34M
Net Debt645.40K564.40K830.62K301.74K248.50K294.27K93.95K589.59K109.20K-1.91M-946.94K-2.79M-3.53M1.44M2.94M197.00K-664.00K-743.00K-4.67M-2.32M-8.49M-11.38M-7.12M-16.33M-57.68M-41.24M-30.57M-9.40M-5.15M7.02M7.60M

Cash Flow

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.50K425.30K-98.79K-14.01K530.72K657.50K940.78K73.98K413.52K2.04M-189.62K2.99M2.04M742.83K-98.33K-566.00K1.90M165.00K-2.54M-417.00K-5.79M-2.84M-3.70M-21.01M-18.48M-16.07M-10.45M-20.28M-5.25M-18.05M-8.00M
Investing Cash Flow-381.10K156.60K-257.73K-443.83K-126.73K-639.87K-519.31K-247.17K-654.84K-314.75K-917.05K-2.47M-1.71M-4.51M-2.46M432.00K-542.00K-753.00K-588.00K-630.00K-921.00K-286.00K-624.00K29.30M60.54M-581.00K-723.00K-1.01M6.73M-722.00K-1.11M
Financing Cash Flow-16.30K-16.30K283.87K688.27K-267.60K-154.04K-121.78K-25.96K168.25K259.37K107.20K1.15M253.90K2.89M2.15M1.72M-302.00K-130.00K6.89M-1.14M12.78M5.77M-179.00K-2.49M147.00K-73.00K24.00K217.00K32.17M6.75M9.58M
Capital Expenditure362.90K456.80K257.72K321.22K126.73K256.08K172.94K220.67K565.91K606.50K910.28K2.47M1.71M4.52M2.47M201.00K542.00K753.00K588.00K630.00K421.00K286.00K624.00K363.00K1.30M581.00K723.00K1.01M533.00K722.00K1.11M
Free Cash Flow-350.40K-31.50K-356.52K-335.23K404.00K401.42K767.84K-146.69K-152.39K1.44M-1.10M511.25K327.97K-3.78M-2.56M-767.00K1.35M-588.00K-3.12M-1.05M-6.21M-3.12M-4.33M-21.37M-19.78M-16.65M-11.17M-21.29M-5.78M-18.77M-9.12M
FCF to OCF-2803.20%-7.41%360.87%2392.79%76.12%61.05%81.62%-198.28%-36.85%70.33%580.05%17.12%16.07%-508.91%2607.06%135.51%71.43%-356.36%123.19%251.08%107.28%110.08%116.85%101.73%107.04%103.62%106.92%104.98%110.15%104.00%113.92%

Earnings

Report DateMar 31, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Mar 31, 2003Jul 30, 2003Nov 3, 2003Mar 30, 2004May 13, 2004Aug 15, 2004Nov 14, 2004Mar 29, 2005May 13, 2005Aug 15, 2005Nov 14, 2005Mar 29, 2006May 10, 2006Aug 9, 2006Nov 7, 2006May 15, 2007Aug 10, 2007Nov 12, 2007May 14, 2008Aug 13, 2008Nov 10, 2008May 8, 2009Aug 10, 2009Nov 9, 2009Mar 16, 2010May 10, 2010Aug 9, 2010Nov 9, 2010Mar 31, 2011May 12, 2011Aug 12, 2011Nov 14, 2011Mar 29, 2012May 15, 2012Aug 14, 2012Nov 14, 2012Mar 31, 2013Apr 1, 2013Aug 14, 2013Nov 14, 2013Mar 31, 2014May 15, 2014Aug 5, 2014Nov 6, 2014Feb 27, 2015May 8, 2015Aug 6, 2015Nov 4, 2015Mar 17, 2016May 11, 2016Aug 1, 2016Oct 26, 2016Mar 9, 2017May 15, 2017Aug 2, 2017Nov 2, 2017Mar 12, 2018May 14, 2018Aug 1, 2018Nov 1, 2018Mar 13, 2019May 8, 2019Aug 7, 2019Nov 11, 2019Mar 16, 2020May 11, 2020Aug 10, 2020Nov 9, 2020Mar 31, 2021May 12, 2021Aug 12, 2021Nov 11, 2021Mar 17, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Mar 16, 2023May 11, 2023Aug 10, 2023Nov 9, 2023Mar 21, 2024May 9, 2024Aug 8, 2024Nov 8, 2024Mar 13, 2025May 7, 2025Aug 7, 2025Nov 6, 2025Mar 10, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate---------------------------------0.030.010.020.01-0.020.020.020.02-------0.020.02--0.00-0.05-0.02---0.10-0.08-0.06-0.06-0.05-0.07-0.02-0.01-0.04-0.03-0.01-0.05-0.01-0.03-0.11-0.10-0.18-0.18-0.18-0.19-0.25-0.21-0.17-0.11-0.14-0.15-0.15-0.11-0.15-0.19-0.14-0.14-0.14-0.09-0.11-0.18-0.19-0.19-0.19-0.16-0.12-0.09-0.10-0.06-0.11-0.06-0.07
EPS Actual-0.010.000.01-0.110.000.020.010.010.010.02-0.00-0.00-0.000.000.030.03-0.020.010.030.030.020.01-0.010.010.020.040.040.050.030.060.030.010.080.020.020.01-0.000.00-0.010.000.00-0.010.030.020.00-0.050.010.01-0.000.020.02-0.06-0.020.00-0.01-0.03-0.03-0.27-0.14-0.06-0.07-0.05-0.07-0.02-0.01-0.04-0.06-0.04-0.040.02-0.03-0.01-0.01-0.10-0.14-0.13-0.13-0.16-0.20-0.18-0.11-0.04-0.14-0.12-0.12-0.06-0.17-0.16-0.17-0.17-0.10-0.11-0.13-0.28-0.22-0.19-0.14-0.12-0.10-0.09-0.05-0.03-0.05-0.07-
Surprise----------------------------------33.33%100.00%-50.00%-121.00%--150.00%-84.50%-99.00%-150.00%-------0.00%0.00%---80.00%-50.00%---40.00%25.00%-16.67%16.67%-40.00%71.43%50.00%-300.00%-50.00%-33.33%-300.00%140.00%-200.00%66.67%90.91%0.00%22.22%27.78%27.78%15.79%20.00%14.29%35.29%63.64%0.00%20.00%20.00%45.45%-13.33%15.79%-21.43%-21.43%28.57%-22.22%-18.18%-55.56%-15.79%0.00%26.32%25.00%16.67%0.00%50.00%46.43%54.55%-16.67%-
Timing---------------------------------Pre-marketPre-marketPre-market--Pre-marketPre-marketPre-marketPre-market------------After-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-market-Pre-marketAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap124.69M
Enterprise Value136.28M
Trailing P/E0.00
Forward P/E72.46
PEG Ratio0.59
Price / Sales2.13
Price / Book11.65
EPS-0.20
Book Value0.253
Revenue (TTM)58.41M
Gross Profit (TTM)37.09M
EBITDA-2.75M
Profit Margin-14.78%
Operating Margin-13.01%
Return on Equity-90.69%
Return on Assets-3.71%
Shares Outstanding42.12M
Shares Float30.50M
Beta1.31
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 3 analystsTarget 6.60
  • Strong Buy
    1
  • Hold
    2

Ownership Breakdown

Institutions
50.58%
Insiders
13.55%
Retail / Other
35.87%

Top Institutional Holders

  • Nantahala Capital Management, LLC
    3.44M8.17%
  • Archon Capital Management LLC
    2.64M6.28%
  • Royce & Associates, LP
    2.61M6.20%
  • Vanguard Capital Management, LLC
    1.56M3.69%
  • Essex Investment Management Company, LLC
    1.14M2.70%
  • AIGH Capital Management, LLC
    1.13M2.68%
  • Silverberg Bernstein Capital Management LLC
    1.04M2.47%
  • Commonwealth Equity Services, LLC
    649.06K1.54%
  • Horizon Asset Management Inc/ny
    615.00K1.46%
  • SEI Investments Co
    598.25K1.42%
  • BlackRock Inc
    527.75K1.25%
  • Taylor Frigon Capital Management LLC
    413.60K0.98%
  • Geode Capital Management, LLC
    391.36K0.93%
  • Legato Capital Management LLC
    382.76K0.91%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    1.10M2.60%
  • Royce Micro-Cap Trust
    973.27K2.31%
  • FTGF RY US SmCp Opp A USD Dis(A)
    754.50K1.79%
  • Royce Small-Cap Opportunity Invmt
    704.32K1.67%
  • RENN Fund ord
    615.00K1.46%
  • Royce Micro-Cap Invmt
    586.78K1.39%